Following the disclosure of these financial figures, the company’s management team will host a conference call on Thursday, August 20, 2026, from 15:30 to 16:30 HKT. The session will feature prepared remarks regarding the firm’s performance, followed by an open question-and-answer period.
Sisram Medical Sets August Date for 2026 Interim Results
Sisram Medical Ltd, the global wellness group specializing in Energy-Based Devices and injectables, has scheduled the release of its unaudited consolidated interim results for the six-month period ending June 30, 2026, for Wednesday, August 19, 2026.
The leadership panel includes Chairman Lior Moshe Dayan, CEO Eyal Ben David, Co-CEO and CFO Jiahong Li, and Investor Relations Director Hui Fan. Stakeholders may attend via teleconference or webcast, with live interpretation provided in both English and Chinese. Participants are required to register in advance through the company’s designated portal. A digital replay will be archived on the Sisram Medical investor relations website shortly after the call concludes.
Comments (0)
No comments yet. Be the first!